Antimicrobial Treatment of Orthopedic and Related Prosthetic Infections
A special issue of Antibiotics (ISSN 2079-6382). This special issue belongs to the section "Antibiotic Therapy in Infectious Diseases".
Deadline for manuscript submissions: closed (31 March 2024) | Viewed by 490
Special Issue Editors
Interests: antimicrobial drugs; antimicrobial resistance; antimicrobial PK/PD
Interests: antibiotic resistance; molecular mechanisms of resistance; bone infection
Interests: primary and revision joint arthroplasty of hip and knee; diagnostics and therapy of bone and joint infections; local antibiotic therapy; antibiotic-loaded bone cement.
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Orthopedics and implant infections are a growing concern. Staphylococcus aureus, one of the main protagonists responsible for related infections, was identified as a human commensal but also as a dangerous pathogen. Due to its growing antibiotic resistance, it is necessary to find numerous antibacterial agents, including new antibiotics, and new strategies to treat these biofilm-associated infections. Different antibiotic combinations are also an effective option. Antibiotics must reach the site of infection both in sufficient concentrations and time in order to be effective. Selection of the ideal antibiotic tissue pharmacokinetic profile depends on the efficacy of the particular antibiotic (e.g., time- and concentration-dependent effects). This Special Issue seeks manuscript submissions to further our understanding of the antimicrobial treatment of orthopedic and related prosthetic infections.
Prof. Dr. Anna Benini
Prof. Dr. Annarita Mazzariol
Prof. Dr. Konstantinos D. Anagnostakos
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antibiotics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- bone infections
- biofilm
- antimicrobial resistance
- new therapeutic strategies
- bone cement
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
